Semaglutide, a GLP-1R agonist, is also effective for MASH patients
Orforglipron -An oral GLP-1R agonist to treat type 2 diabetes
Gut microbiota and its metabolites can predict anti-tumor immunotherapy efficacy
How Diet Coke causes atherosclerotic plaque – mechanism unlocked!!
Brentuximab Vedotin Combination Approved for Relapsed/Refractory Large B-Cell Lymphoma
Over-exercise leads to liver fibrosis
Anaphylaxis Alert: New Safety Concerns Emerge for Glatiramer Acetate
Diet improving gut microbiome provides cardiometabolic benefits
Semaglutide: A Breakthrough in Obesity Treatment
Shivering can make you healthy
Based on Phase 3 trial data, the FDA approved Alhemo for the treatment of hemophilia-related bleeding
Semaglutide Enhances Glycemic Control with Automated Insulin Delivery in Type 1 Diabetes
Expanding Global Access to Mpox Vaccines: A Strategic Partnership Between Bavarian Nordic and Serum Institute of India
Intermittent fasting can cause hair loss, amid all the health gains
Scientists explained why you gain weight quickly after stopping dieting
Avoiding sugars in the first 1000 days of life can reduce the risk of type 2 diabetes and hypertension in your 60s – A World War II sugar rationing study
A snapshot of worldwide diabetes prevalence over 30 years: 1990-2022
FDA Approves Obecabtagene Autoleucel for Advanced B-Cell Acute Lymphoblastic Leukemia
A non-invasive biomarker panel for MASH
FDA Certifies Vyloy as a Novel Approach Against Gastric Cancer: a CLDN18.2-Targeted Therapy
FDA Approves Zolbetuximab-clzb for Advanced Gastric and GEJ Adenocarcinoma
FDA Approval of Inavolisib Combination Therapy for PIK3CA-Mutated, HR-Positive, HER2-Negative Breast Cancer
Blood glucose as a predictor of cardiovascular events
Nivolumab Approved for Neoadjuvant and Adjuvant Therapy in Resectable NSCLC: A New Horizon for Lung Cancer Treatment
First iPSC- Islet Transplantation in Humans- Proceed with Caution
Wegovy®: Expanding Benefits for Obesity-Related Heart Failure with Preserved Ejection Fraction
Recent FDA Approvals pack Double punches against Niemann-Pick disease type C
Transparent mice are here – Not a science fiction, but a reality.
Nanotechnology: Revolutionizing Diabetes Treatment and Diagnostics